Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Return on Capital Employed (2021 - 2025)

Krystal Biotech's Return on Capital Employed history spans 5 years, with the latest figure at 0.14% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 6.0% year-over-year to 0.14%; the TTM value through Dec 2025 reached 0.14%, up 6.0%, while the annual FY2025 figure was 0.15%, 7.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.14% at Krystal Biotech, up from 0.07% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.14% in Q4 2025 and bottomed at 0.27% in Q4 2022.
  • The 5-year median for Return on Capital Employed is 0.13% (2021), against an average of 0.1%.
  • The largest annual shift saw Return on Capital Employed fell -14bps in 2022 before it increased 21bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.13% in 2021, then crashed by -103bps to 0.27% in 2022, then surged by 47bps to 0.14% in 2023, then soared by 150bps to 0.07% in 2024, then soared by 90bps to 0.14% in 2025.
  • Per Business Quant, the three most recent readings for KRYS's Return on Capital Employed are 0.14% (Q4 2025), 0.07% (Q4 2024), and 0.03% (Q3 2024).